Comparison of Clinical Outcomes Among Patients Treated With Tisagenlecleucel

Clinical trial NCT05541328 · COMPLETED

Trial details

NCT number: NCT05541328
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Diffuse Large B-cell Lymphoma

Start date: 2020-02-03
Primary completion: 2021-02-05
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.